BACKGROUND: Increased rates of exposure to Toxoplasma gondii have been found in individuals with schizophrenia as compared with control groups, but the correlates of Toxoplasma exposure in schizophrenia have not been defined. METHODS: We measured IgG class antibodies to Toxoplasma gondii in 358 individuals with schizophrenia. We correlated Toxoplasma antibody status with clinical and demographic variables and examined the effect of Toxoplasma seropositivity on mortality in a follow-up period of up to 5 years. RESULTS: Individuals with schizophrenia who had serological evidence of Toxoplasma infection were more likely to be female but did not differ in age, race, total symptom score, or other demographic or clinical characteristics. However, we found that serological evidence of Toxoplasma was associated with a significantly increased risk of dying of natural causes during the follow-up period (Cox proportional hazard ratio of 4.70; 95% confidence interval, 1.27-17.31, P = .020) adjusted for age, gender, and other clinical and demographic variables. CONCLUSIONS: Toxoplasma infection may confer an increased risk for mortality from natural causes in schizophrenia. An understanding of the pathogenesis of Toxoplasma infections in individuals with schizophrenia might lead to new approaches to the management of this disorder.
BACKGROUND: Increased rates of exposure to Toxoplasma gondii have been found in individuals with schizophrenia as compared with control groups, but the correlates of Toxoplasma exposure in schizophrenia have not been defined. METHODS: We measured IgG class antibodies to Toxoplasma gondii in 358 individuals with schizophrenia. We correlated Toxoplasma antibody status with clinical and demographic variables and examined the effect of Toxoplasma seropositivity on mortality in a follow-up period of up to 5 years. RESULTS: Individuals with schizophrenia who had serological evidence of Toxoplasma infection were more likely to be female but did not differ in age, race, total symptom score, or other demographic or clinical characteristics. However, we found that serological evidence of Toxoplasma was associated with a significantly increased risk of dying of natural causes during the follow-up period (Cox proportional hazard ratio of 4.70; 95% confidence interval, 1.27-17.31, P = .020) adjusted for age, gender, and other clinical and demographic variables. CONCLUSIONS:Toxoplasma infection may confer an increased risk for mortality from natural causes in schizophrenia. An understanding of the pathogenesis of Toxoplasma infections in individuals with schizophrenia might lead to new approaches to the management of this disorder.
Authors: Faith B Dickerson; John J Boronow; Cassie R Stallings; Andrea E Origoni; Robert H Yolken Journal: Am J Psychiatry Date: 2003-12 Impact factor: 18.112
Authors: Jitka Lindová; Martina Novotná; Jan Havlícek; Eva Jozífková; Anna Skallová; Petra Kolbeková; Zdenek Hodný; Petr Kodym; Jaroslav Flegr Journal: Int J Parasitol Date: 2006-08-31 Impact factor: 3.981
Authors: Alan S Brown; Catherine A Schaefer; Charles P Quesenberry; Liyan Liu; Vicki P Babulas; Ezra S Susser Journal: Am J Psychiatry Date: 2005-04 Impact factor: 18.112
Authors: Preben Bo Mortensen; Bent Nørgaard-Pedersen; Berit Lindum Waltoft; Tina L Sørensen; David Hougaard; E Fuller Torrey; Robert H Yolken Journal: Biol Psychiatry Date: 2006-08-22 Impact factor: 13.382
Authors: Donald C Goff; Corinne Cather; A Eden Evins; David C Henderson; Oliver Freudenreich; Paul M Copeland; Michael Bierer; Kenneth Duckworth; Frank M Sacks Journal: J Clin Psychiatry Date: 2005-02 Impact factor: 4.384
Authors: Jaana Suvisaari; Minna Torniainen-Holm; Maija Lindgren; Tommi Härkänen; Robert H Yolken Journal: J Affect Disord Date: 2017-07-10 Impact factor: 4.839
Authors: F M Notarangelo; E H Wilson; K J Horning; M A R Thomas; T H Harris; Q Fang; C A Hunter; R Schwarcz Journal: Schizophr Res Date: 2013-12-15 Impact factor: 4.939